Swiss National Bank - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 137 filers reported holding ARRAY BIOPHARMA INC in Q1 2016. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$18,815,000
+109.2%
406,100
+10.1%
0.02%
+100.0%
Q1 2019$8,994,000
+76.7%
368,900
+3.3%
0.01%
+42.9%
Q4 2018$5,089,000
-4.1%
357,100
+2.3%
0.01%
+16.7%
Q3 2018$5,305,000
-7.9%
349,000
+1.6%
0.01%
-14.3%
Q2 2018$5,762,000
+8.4%
343,400
+5.5%
0.01%
+16.7%
Q1 2018$5,314,000
+34.5%
325,600
+5.5%
0.01%
+50.0%
Q4 2017$3,951,000
+6.2%
308,700
+2.1%
0.00%0.0%
Q3 2017$3,720,000
+66.2%
302,400
+13.1%
0.00%
+33.3%
Q2 2017$2,238,000
+0.1%
267,400
+7.0%
0.00%0.0%
Q1 2017$2,235,000
+5.2%
250,000
+3.4%
0.00%0.0%
Q4 2016$2,125,000
+23.1%
241,800
-5.4%
0.00%0.0%
Q3 2016$1,726,000
+128.9%
255,700
+20.8%
0.00%
+200.0%
Q2 2016$754,000
+12.7%
211,700
-9.8%
0.00%0.0%
Q1 2016$669,000
-17.1%
234,800
+22.8%
0.00%
-50.0%
Q4 2015$807,000
-7.5%
191,2000.0%0.00%0.0%
Q3 2015$872,000
-27.3%
191,200
+15.0%
0.00%
-33.3%
Q2 2015$1,199,000
+13.0%
166,300
+15.5%
0.00%0.0%
Q1 2015$1,061,000
+55.8%
144,0000.0%0.00%0.0%
Q4 2014$681,000
+38.4%
144,000
+4.6%
0.00%
+50.0%
Q3 2014$492,000
-21.7%
137,7000.0%0.00%0.0%
Q2 2014$628,000
-2.9%
137,7000.0%0.00%
-33.3%
Q1 2014$647,000
+18.1%
137,700
+25.9%
0.00%
+50.0%
Q4 2013$548,000
-19.4%
109,4000.0%0.00%
-33.3%
Q3 2013$680,000
+31.5%
109,400
-3.9%
0.00%
+50.0%
Q2 2013$517,000113,8000.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
BVF INC/IL 6,290,586$95,617,0008.40%
Redmile Group, LLC 15,906,680$241,782,0007.44%
First Light Asset Management, LLC 2,381,146$36,193,0005.84%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 844,500$9,844,0004.68%
PACIFIC VIEW ASSET MANAGEMENT, LLC 355,157$5,397,0004.30%
SECTORAL ASSET MANAGEMENT INC 2,094,167$31,831,0003.38%
X-Square Capital, LLC 183,862$2,795,0001.85%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 334,604$5,086,0001.67%
Birchview Capital, LP 128,000$1,946,0001.26%
Rhenman & Partners Asset Management AB 768,370$11,679,0001.17%
View complete list of ARRAY BIOPHARMA INC shareholders